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Abstract
Objective: To assess hepatic steatosis by ultrasound method as a concomitant risk factor among overweight 
adolescents.
Methods: A case-control study including 83 cases (47 overweight and 36 obese) and 89 controls (normal 
weight), frequency matched by gender, year of birth, pubertal stage (Tanner 4/5), and income. Cases and controls 
were selected from 1,420 students enrolled in a Vila Mariana public high school, in São Paulo, Brazil. Must et al. 
criteria were used for nutritional status classification. Nonalcoholic fatty liver disease was diagnosed through hepatic 
ultrasonography performed and analyzed by one radiologist. Hepatic enzymatic activities (alanine and aspartate 
transaminases, alkaline phosphatase, gamma-glutamyl transpeptidase) and direct bilirubin were measured. Eight 
covariables were fitted into logistic regression models; criterion for inclusion of variables was the association with 
overweight in the bivariate analyses (p < 0.20). A value of p < 0.05 was set as the criterion for inclusion into the 
final logistic regression models.
Results: Prevalence of hepatic steatosis diagnosed through ultrasonography was 27.7% in overweight/obese 
students and 3.4% in normal weight students. Adjusted odds ratios (95%CI) for images compatible with nonalcoholic 
fatty liver disease and gamma-glutamyl transpeptidase > 24 U/L were 10.77 (2.45-47.22) and 4.18 (1.46-11.94), 
respectively. 
Conclusions: This is the first population-based study showing that hepatic steatosis is strongly associated with 
overweight/obesity among adolescents attending a Brazilian public school. The diagnostic tool used in this investigation 
is a non-invasive method that might be applied to monitor overweight and obese adolescents and to propose actions 
for preventing more severe hepatic diseases in adulthood.
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Introduction 
Obesity in adulthood is a limiting factor for quality of life 
and longevity. Pediatricians’ attention to the consequences 
of obesity in childhood and adolescence have probably 
begun due to the significant increase of its prevalence in 
both developed and developing countries.1
Between 1980 and 1994, the proportion of children and 
adolescents considered obese increased 100% in the USA.2 
It is estimated that 15.3% of American children aged 6-11 
years and 15.5% of adolescents aged 12-19 years present 
body mass index (BMI) ≥ 95th percentile. Approximately 
11% of American children and adolescents between 6 and 
17 years old are obese. High prevalence of obesity has been 
observed in populations of developing countries1 and low 
socioeconomic level.3
A national survey4 verified that 32% of the Brazilian 
adult population presented some degree of overweight or 
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obesity. This survey also showed incidences of 10.4% for 
overweight and 1.8% for obesity in adolescents aged 10-19 
years according to the Cole et al. criterion.5 Considering 
the Must et al. criterion the prevalence of overweight 
(BMI > 85th) was 17.9%.5 
Obese children and adolescents present higher 
probabilities of becoming obese adults with a greater 
risk of developing cardiovascular diseases, diabetes and 
some types of neoplasia than normal weight children and 
adolescents.6 Obese children and adolescents also present 
higher frequencies of dyslipidemia, diabetes, hypertension, 
orthopedic and postural disorders, dermatitis and respiratory 
disfunction.7 
Nonalcoholic fatty liver disease (NAFLD) could be 
defined as alterations of the hepatic function and damage 
to hepatic tissues similar to those observed in alcoholic 
liver disease.8 Childhood obesity prevalence has increased 
and NAFLD has been considered as a relevant disease 
in children.9 The high prevalence of NAFLD in children 
was recognized only in the past 5 to 10 years, as rates 
of childhood obesity rose.10 NAFLD includes a broad 
spectrum of liver tissue alterations, ranging from pure 
hepatic steatosis (HS) without inflammation to nonalcoholic 
steatohepatitis (NASH) with inflammation and fibrosis, 
and cirrhosis.8,9
Studies of the asymptomatic liver involvement in obese 
pediatric patients showed greater frequencies of HS and 
steatohepatitis that had already been reported in the 
literature of adult obese populations.11 
NAFLD affects 10 to 24% of the general population in 
several countries. NAFLD ranges from simple steatosis, 
which is the least rapidly progressing disorder to NASH 
and to cirrhosis that can evolve to chronic liver failure.10 
The early detection and control of hepatic alterations is 
important because their progression could raise mortality 
rates due to cirrhosis among young adults. Two such cases 
have been reported in obese children, one in a 10-year-old 
with BMI of 32 kg/m2 and another in a 14-year-old, BMI of 
37.9 kg/m2, with NASH that progressed to cirrhosis with 
symptoms of portal hypertension in 2 years.12 Disease 
mechanisms in those cases involved hyperinsulinemia and 
hepatic insulin resistance, which were not related to ethanol 
consumption.10 
HS seems to be caused by the availability and mobilization 
of free fatty acids (FFA), by increased hepatic FFA synthesis, 
esterification of FFA into triglycerides and decrease of 
triglyceride transportation within the liver. According to the 
standing theory, there would be a deviation of lipolysis in favor 
of lipogenesis.13 The circulating FFA would develop peripheral 
insulin resistance that could evolve to systemic resistance. 
HS is currently considered one of the aspects associated 
with insulin resistance, along with type II diabetes mellitus, 
visceral obesity, dyslipidemia and hypertension.14 
The relevant diagnosis of NASH requires a liver biopsy, 
since some individuals have inflammation and fibrosis 
despite having normal serum ALT.9 
The noninvasive ultrasound method was adopted due 
to better sensitivity (89%) and specificity (93%) for the 
detection of HS15 when compared to the gold standard 
hepatic biopsy.
The objective of the present study was to evaluate 
HS by ultrasound method as a concomitant risk factor of 
overweight and obesity within a low income adolescent 
population attending a Brazilian public high school.
Materials and methods
The case-control study was carried out in the city of 
São Paulo, State of São Paulo, Southeast Brazil, from June 
through December 2002.
For the selection of cases and controls, a team of trained 
nutritionists and pediatricians weighed and measured 1,420 
adolescents born between 01/01/1983 and 12/31/1988, 
accounting for 98.68% of all students enrolled in a public 
high school of São Paulo. Sixteen youngsters refused to be 
evaluated, and three were not found after at least three 
attempts.
From the screened adolescents, 104 were classified as 
overweight and obese with BMI ≥ 89th and adolescents were 
considered obese when BMI > 95th according to the Must 
et al. criterion.16 Controls (114) were frequency matched 
by age, gender and pubertal development, and income, 
and were randomly selected from subjects presenting BMI 
between 5th and 85th percentiles.16 
The adolescents were measured by trained nutritionists 
during their physical education classes and, when eligible 
to participate, were invited to come to school with their 
parents on a Saturday morning to be informed on the 
research objectives and to obtain the parents’ signature 
on the informed consent form. Of the 218 (104 cases and 
114 controls) eligible adolescents, 19.4% (17 cases and 
25 controls) refused to participate and two subjects (one 
case and one control) were excluded due to hypothyroidism 
diagnosed after medical examination and assessment of 
thyroid hormones levels. Adolescents using drugs that 
compromise hepatic functions were excluded. Other risk 
factors such as viral hepatitis and inborn errors of metabolism 
were not considered. The final sample study comprised 
172 adolescents: 47 overweight, 36 obese as cases and 
89 normal weight as controls. 
A standardized and pretested questionnaire was applied 
by trained nutritionists and pediatricians to both cases and 
controls. The following variables were considered: frequency 
and duration of physical activity (habit of napping, walking 
less than 1 hour per day, hours of television watching, 
videogames and computer playing per day); eating habits 
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analyzed by total fat intake, eating restriction, use of drugs 
for weight loss reasons; alcohol intake (consumption of 
alcohol equal to or higher than three times a week), and 
relationships (having a best friend; a boy/girl friend). 
Questions regarding the use of alcohol were made to the 
adolescents in private without the presence of parents in 
order to avoid any embarrassment.
In addition to the interview with the adolescent, parents 
or guardians were also interviewed. At the time, data were 
collected concerning the adolescent (birth weight, past 
obesity) and the biological parents (weight and height, 
measured by trained nutritionists). Parents were considered 
obese when presenting BMI > 30 kg/m2.
One of the graduate students involved in the project 
measured the participants’ blood pressure according to the 
procedures recommended for field work.17 High systolic or 
diastolic blood pressure was defined as a value that exceeded 
the 95th percentile for age and gender.17 
The adolescents were referred to the Outpatient Clinic 
to undergo hepatic ultrasonography and laboratory tests. 
The hepatic ultrasounds were performed and interpreted by 
one trained radiologist from the staff of the Department of 
Imaging Diagnosis, Pediatric Radiology Sector, Universidade 
Federal de São Paulo (UNIFESP), São Paulo. The equipment 
used was the LOGIQ 400 PRO-GE model. Liver steatosis 
was graded as mild, moderate and severe, according to 
Saverymuttu et al.15 
The laboratory tests were performed at the UNIFESP 
Psychobiology Laboratory. Blood samples were collected 
by peripheral venous puncture in the morning, after 12 
to 14-hour fasting. All patients were tested for serum 
concentrations of alanine (ALT) and aspartate (AST) 
transaminases, gamma-glutamyl transpeptidase (GGT), 
alkaline phosphatase, cholesterol, and triglycerides were 
tested, as well as fasting plasma glucose, fasting plasma 
insulin concentrations, and glycosylated hemoglobin. The 
reference value adopted for AST was 37 U/L, 30 U/L for ALT, 
24 U/L for GGT (75th percentile of the total sample), 126 
U/L for the alkaline phosphatase and 0.30 mg/dL for direct 
bilirubin. All adolescents included in this study presented 
AST/ALT ratio lower than 1, which indicates that they do 
not have alcoholic-related liver disease.
The degree of insulin resistance was determined by 
the homeostatic model assessment-insulin resistance 
(HOMA) calculating the product of the fasting plasma insulin 
concentration (in microunits per milliliters) and the fasting 
plasma glucose concentration (in millimoles per liter) divided 
by 22.5.18,19 Risk of insulin resistance was defined for values 
greater than 2 (HOMA > 2).19
Statistical analysis
Data were codified by the interviewers daily, and revised 
by the field study coordinator. The database was structured 
using Epi-Info 6.0 software and double entered for correction 
of possible entry mistakes. Analyses were performed using 
Stata software.
Sample size allowed for detection of an odds ratio (OR) 
of 3.00, given a prevalence of family obesity among controls 
of 25%. Assuming 80% power and 5% alpha error, the 
result was 65 cases and 65 controls. This was increased by 
10% possible losses and 10% stratified analysis leading to 
a total sample of 78 cases and 78 controls.
Continuous variables were presented as means and 
standard deviations and for comparisons between obese/
overweight and normal weight adolescents. The Student’s 
t test was adopted to compare means between the groups 
(Table 1).
Initially, the univariate analysis of all information 
collected was carried out calculating the proportions for the 
dichotomous variables. As the next step, bivariate analyses 
were performed, observing exposure prevalence for cases 
and controls, association test (Pearson’s chi-squared test) 
and OR with their respective confidence intervals (95%CI). 
Finally, the multivariate analysis was carried out – a 
conditional logistic hierarchical regression model. In each 
hierarchical level the variables associated to overweight 
with p < 0.20 were maintained for their status of possible 
confounders. In the final models only univariables with 
p < 0.05 were kept.
Ethical considerations
The present study was approved by the Ethics 
Committee of UNIFESP, according to the Declaration of 
Helsinki, World Medical Association. Adolescents presenting 
ultrasonography or biochemical hepatic enzymes suggestive 
of HS were referred to the Pediatric Hepatology Unit of our 
university. 
Results
The prevalence of obesity (BMI ≥ 95th) and overweight 
(BMI between 85th and 95th) in the universe of 1,420 
students from which cases and controls were selected, was 
4.4 and 10.8%, respectively. 
Table 1 depicts the descriptive variables of adolescents 
and their parents for cases and controls, including the Tanner 
classification for puberal stage and biochemical profiles. 
Prevalence of risk factors for cases and controls, as well as 
the crude and adjusted OR are shown in Table 2. 
As for the hepatic ultrasonography, it was verified that 
the chances of presenting HS in any degree was 10.99 times 
greater among the cases than in the controls. In this study, 
23 (27.7%) overweight/obese adolescents presented some 
degree of steatosis (21 mild and two moderate) whereas 
only three adolescents with mild HS (3.4%) were found in 
the control group.
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As far as the hepatic enzymes are concerned, it was 
observed that the chances of presenting GGT above 24 
U/L were 3.70 times greater in cases than in controls. Only 
two adolescents had GGT higher than the normal values 
(78 U/L). Chances for ALT above 30 U/L were 2.46 times 
greater in the cases than in the controls. As additional 
information, not included in the tables, when elevated 
ALT and presence of steatosis were considred together, 
there were 12 adolescents in the case group with both 
abnormalities, whereas in the control group no subject had 
the two alterations. The chances of presenting increased 
AST and alkaline phosphatase were 1.79 and 1.01 times 
greater in cases than in controls, respectively, but with no 
statistical significance. 
The hierarchical conditional logistic regression for 
overweight, considering HS indicators as concomitant risks 
is depicted in Table 3. 
The adjusted OR shown in the multivariate analyses for 
parents’ history, past obesity and relationships/behavior 
considered in model 1 were all strongly associated to 
overweight adolescence, and are discussed in greater detail 
elsewhere.20 The variables of restrictive diets for weight loss, 
habit of napping, presence of HS in the ultrasonography, 
GGT and ALT were considered in model 2. Restrictive 
diets and habit of napping, presence of HS, increased 
GGT and ALT maintained the statistical significance. The 
overweight/obesity group had 10.77 times greater chances 
of presenting ultrasonography HS than the normal weight 
adolescents. The chances for alterations of GGT in the 
multivariate analyses were 4.18 times higher among cases 
when compared with controls.
Discussion
The prevalence of overweight/obesity found in this study 
(15.2%) is in accordance with the findings of other Brazilian 
epidemiological studies of low-income populations.20 Certain 
ethnicities are predisposed to NAFLD such as the Hispanic, 
mainly non-Cuban, Asian, specifically from China and the 
Philippines, and indigenous people of North and South 
America.9 Ethnic miscegenation constitutes an important 
characteristic of the Brazilian population, one that does not 
allow for commitments with specific ethnic groups.
Variables Cases (n = 83) Control (n = 89) p*
Age (years)  16.0±1.0 15.9±0.9 0.63
Male, n (%) 38 (45.8) 43 (48.3) 0.74
BMI, kg/m2 29.7±2.8 20.2±1.9 0.00
Tanner’s criterion 4 or 5, % 100 100 
Birth weight (g)  3,215±628 3,213±552 0.99
BP    
 Systolic BP, mmHg  116±14 103±11 0.00
 Diastolic BP, mmHg  73±9 65±8 0.00
Lipid profile    
 TC mg/dL  167.8±28.5 159.1±26.7 0.03
 HDLc mg/dL  45.5±11.4 51.1±10.0 0.00
 LDLc mg/dL  102.2±25.2 93.1±23.9 0.01
 VLDLc mg/dL  20.1±1.0 14.8±4.4 0.00
 Triglycerides mg/dL  100.3±49.9 74.0±22.0 0.00
Ultrasonography   
 Hepatic steatosis (mild/moderate) 21 (2) 3 (0) 
Hepatic function   
 GGT U/L 27.0±20.8 19.6±5.5 0.00
 ALT U/L 34.3±14.0 29.5±10.8 0.01
 AST U/L 24.4±7.6 25.4±13.7 0.58
 Alkaline phosphatase U/L 102.9±43.0 101.4±51.6 0.84
 Direct bilirubin mg/dL 0.2±0.1 0.2±0.1 0.21
CHO metabolism   
 HOMA 2.8±1.7 1.6±0.8 0.00
 FB insulin concentration µU/L 13.7±0.5 1.8±0.4 0.00
 FB glucose concentration mg/dL 84.1±6.4 82.9±6.0 0.00
Table 1 - Descriptive statistics for cases and controls
ALT = alanine transaminase; AST = aspartate transaminase; BMI = body mass index; BP = blood pressure; CHO = carbohydrates; FB = fasting blood; GGT = gamma-
glutamytranspeptidase; HDLc = high-density lipoprotein cholesterol; HOMA = homeostatic model assessment; LDLc = low-density lipoprotein cholesterol; TC = total 
cholesterol; TG = triglycerides; VLDLc = very low density lipoprotein cholesterol.
* Student’s t test.
Results shown in mean ± standard deviation.
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    Crude OR  
Risk factors Cases, % Controls, % (95%CI) p
Parents’ history     
 Parents’ BMI (≥ 30 kg/m2) 51.8 34.5 2.04 (1.05-4.00) 0.022*
Past obesity     
 Infant 29.3 10.2 3.63 (1.46-9.24) 0.002*
 Pre-school period 29.3 2.3 17.79 (3.80-114.97) 0.000*
 School age 43.9 10.2 6.87 (2.84-17.08) 0.000*
 Adolescence 36.6 6.8 7.88 (2.85-23.00) 0.000*
 All periods 18.1 1.1 19.41 (2.55-10.49) 0.000*
Relationships/behavior     
 Having a best friend 94.0 74.2 5.44 (1.81-17.53) 0.087*
 Having a boy/girlfriend 18.1 29.2 0.53 (0.24-1.16) 0.000*
 Treatment of obesity    
 Eating restriction 48.2 13.1 6.17 (2.69-14.45) 0.000*
 Use of drugs for weight loss reasons 9.8 1.2 8.65 (1.04-191.99) 0.018*
Health habits     
 Alcohol intake ≥ 3 times/week 7.2 21.3 0.29 (0.10-0.83) 0.009*
 Total fat intake > 30% of total calorie intake 49.4 61.4 0.61 (0.31-1.21) 0.124
Physical activity     
 Physical activity < 3 times/week and < 30 minutes 77.1 71.9 1.32 (0.62-2.80) 0.434
 Hours of TV/video/computer watching ≥ 4 h/day 19.3 18.0 1.09 (0.47-2.53) 0.827
 Habit of napping 28.9 16.9 2.01 (0.91-4.48) 0.059*
 Walking < 1 h/day 41.0 40.4 1.02 (0.53-1.98) 0.945
Metabolic repercussions     
 Resistance to insulin (HOMA > 2) 68.3 23.9 6.87 (3.30-14.46) 0.000*
 Dyslipidemia 38.6 9.0 6.35 (2.53-16.47) 0.011*
 Hypertension 14.5 2.2 7.35 (1.47-49.94) 0.011*
Ultrasonography     
 Hepatic steatosis (mild and moderate) 27.7 3.4 10.99 (2.92-48.84) 0.000*
Laboratory exams     
 GGT > 24 U/L 36.6 13.5 3.70 (1.63-8.54) 0.000*
 AST > 37 U/L 9.6 5.6 1.79 (0.50-6.71) 0.318
 ALT > 30 U/L 53.0† 31.5‡ 2.46 (1.25-4.84) 0.004*
 Alkaline phosphatase > 126 U/L 19.3 19.1 1.01 (0.44-2.32) 0.976
 Direct bilirubin > 0.30 mg/dL 16.9 23.9 0.65 (0.28-1.48) 0.257
 HDLc < 35 mg/dL 19.3 3.4 6.85 (1.75-31.29) 0.000*
 LDLc > 130 mg/dL 12.0 5.6 2.30 (0.67-8.24) 0.135
 Total cholesterol > 200 mg/dL 15.7 5.6 3.12 (0.96-10.71) 0.031*
 Triglycerides > 150 mg/dL 14.5 1.1 14.87 (1.91-318.82) 0.000*
Table 2 - Prevalences of risk factors for cases and controls, OR with respective confidence intervals
95%CI = 95% confidence interval; ALT = alanine transaminase; AST = aspartate transaminase; BMI = body mass index; GGT = gamma-glutamyl transpeptidase; 
HDLc = high-density lipoprotein cholesterol; HOMA = homeostatic model assessment; LDLc = low-density lipoprotein cholesterol; OR = odds ratio.
* Significant p values.
†
 30% ALT < 40 U/L and 23% ALT > 40 U/L. 
‡
 20.3% ALT < 40 U/L and 11.2% ALT > 40 U/L. 
p = chi square test.
The risk factors identified in Model 1, which are parents’ 
obesity, infants’ obesity, having a best friend, eating 
restriction and habit of napping are thoroughly discussed 
elsewhere.21 
Case and control had significant difference in incidences 
of metabolic disorder parameters that showed that clinical 
metabolic repercussions were associated with the increase 
of body fat mass. Metabolic disorders may develop 
progressively in the course of life; obesity frequently 
coming first followed by hyperlipidemia and diabetes. The 
literature reports evidence that obesity causes secondary 
hyperlipidemia,8 hypertriglyceridemia increasing by five 
to six times the risk of NAFLD. Acquired obesity seems to 
lead to fatty liver.22 Increased concentration of FFA in the 
plasma or hepatocytes should be a crucial factor in the 
development of HS and inflammation.23,24 The initial insult 
would be the development of macrovesicular steatosis with 
the accumulation of hepatic fat from decreased hepatic free 
fatty acid oxidation and/or increased hepatic lipogenesis, 
and/or decreased lipid export from the liver.8 As shown in 
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other studies, resistance to insulin is strongly related to 
risk factors for HS, including obesity and dyslipidemia.25,26 
Resistance to insulin, as measured by the HOMA, had 
greater prevalence in overweight and obese adolescents. 
The presence of mild resistance to insulin could be the 
first stage of NAFLD and it is related to the most advanced 
stages of NAFLD in the most severe cases (type II diabetes); 
therefore, it is directly related to the degree of hepatic 
involvement.27 Alterations in the fasting plasma glucose 
concentration or in glycosylated hemoglobin were not 
observed in the present study. Disorders of the metabolism 
of glucose, from alterations of glycemia under fasting to the 
tolerance to glucose, as well as diabetes, are all significantly 
associated with HS. Family history of type II diabetes was 
found to increase the risk of this disease.8 The association of 
excess body fat with diabetes, hypertension and/or altered 
lipid metabolism has been identified as a distinct entity 
referred to as metabolic syndrome carrying a high risk of 
cardiovascular disease.8 Authors refer NAFLD and NASH as 
hepatic expressions of the metabolic syndrome.28
The hepatic ultrasonography should be the first imaging 
method to be requested by the physician for overweight 
children and adolescents, since it is a good method to 
identify fatty liver. There is a diffuse increase in echogenicity, 
which is usually described as bright liver.12 The prevalence 
of fatty liver was 15.1% (26/172) among adolescents. In a 
retrospective review of 742 children and adolescents who 
had an autopsy performed by a county medical examiner, 
the prevalence of fatty liver adjusted for age, gender, race, 
and ethnicity was estimated at 9.6%. Fatty liver prevalence 
increases with the age ranging up to 17.3% for the ages 
15 to 19 years,29 so this period of life is critical for the 
development of fatty liver disease.30 
The hepatic ultrasonography presented a high prevalence 
of HS in the group of cases. Even after adjustments for the 
remaining variables analyzed, the multivariate analysis 
showed that the HS had 10.77 times greater chances of 
occurring among the cases than in the control group. 
A study performed with 72 obese children and adolescents 
(4-16 years) found that 53% had fatty liver verified in the 
sonogram.1 Yet, in another study with 36 children (4-16 
years) from whom 83% were obese, 24 (77.4%) showed 
abnormalities including hepatomegaly and increased 
echogenicity suggestive of fatty infiltration. Among obese 
individuals, HS prevalence varied from 57.5 to 74%.31,32 
For child populations such prevalence is estimated to be 
2.6%,33 whereas for obese children HS prevalence in different 
studies varied from 22.5 to 52.8%.1,30 In morbid obesity34 an 
increase of echogenicity was found in 58.8% of patients with 
abdominal pain symptomatology and altered the biochemical 
hepatic enzymatic concentrations. Children who have any 
stage of NAFLD are usually overweight or obese, although 
one study has shown NAFLD in approximately 10% of not 
overweight children.9 
Thus, when the present study results are compared with 
the literature, one observes that the patients included in 
Table 3 - Hierarchical conditional logistic regression for overweight, considering hepatic steatosis indicators as concomitant risk factors 
among public high school adolescents (São Paulo, Brazil)
95%CI = 95% confidence interval; ALT = alanine transaminase; AST = aspartate transaminase; BMI = body mass index; GGT = gamma-glutamyl transpeptidase.
* Significant p values.
Model 1 = parents’ BMI, infant obesity, having a best friend, alimentary restriction and habit of napping. 
Model 2 = hepatic steatosis, GGT > 24 U/L and ALT > 30 U/L.
p = chi-square test.
Variables (yes = risk) Adjusted OR (95%CI) p Model
Parents’ history   
 Parents’ BMI ≥ 30 kg/m2 2.57 (1.09-6.04) 0.018* 1
Past obesity   
 Infant period 4.24 (1.41-12.67) 0.005* 1
Relationship/behavior   
 Having a best friend 9.20 (2.16-39.07) 0.003* 1
Treatment of obesity   
 Eating restriction 7.57 (2.78-20.57) 0.000* 1
Sedentary lifestyle   
 Habit of napping 2.99 (1.04-8.60) 0.012* 1
Ultrasonography   
 Hepatic steatosis 10.77 (2.45-47.22) 0.002* 2
Laboratory exams   
 GGT > 24 U/L 4.18 (1.46-11.94) 0.007* 2
 ALT > 30 U/L 1.38 (0.53-3.54) 0.500* 2
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the above mentioned studies were children and adolescents 
that had been followed by a specialist physician in an obese 
health care institution. Otherwise, the subjects of this 
study were selected from adolescents attending a public 
high school. In terms of external validity, the findings of 
this study can be safely extrapolated to urban overweight 
and obese adolescents of low income in other developing 
population. The fact that high prevalence of mild fatty liver 
occurs in overweight adolescents shows that overweight 
increases the risk for development of such a disease, adding 
to environmental and genetic risk factors that speed up the 
progression of hepatic injury. 
The current literature indicates that in the NAFLD the 
increase in transaminases is solely represented by ALT rather 
than by AST; serum AST abnormalities occur exclusively 
in severe fatty liver cases.28,35 They also reported that the 
values of alkaline phosphatase and direct bilirubin tend to 
be normal in NAFLD.1,34 
The present study was based on a community student 
population and has shown that there was a significant 
difference in ALT values between the overweight and the 
control group; 12 adolescents of the case group had some 
degree of fatty liver with ALT values higher than 30 U/L, which 
could be interpreted as evolution from HS to steatohepatitis. 
Therefore, many children have normal liver tests, notably 
normal serum aminotransferase and presumed to have 
simple steatosis. A small proportion of those children might 
have NASH histologically despite normal liver tests.9 In the 
literature, adolescents had a lot of environmental risk fators 
such as drugs, medications and infeccious diseases that 
might alter ALT values, but the increase of body mass have 
to be considered as an important factor for the development 
of HS. The literature indicates that the increase of body fat 
mass will improve the hepatic injury, increasing the degree 
of HS and evolving to steatohepatitis.14 Insulin resistance 
seems to be the primary factor to result in hepatic fat 
accumulation, followed by oxidative stress, mitochondrial 
dysfunction and adipocytokines; the association of these 
factors promote inflammation and liver disease (necrosis 
and fibrosis).14,30
Among adult population, the diagnosis of HS is often 
made by means of routine biochemical exams, revealing 
alterations in transaminases, which occur differently in 
children and adolescents in whom there is a gradual increase 
of these enzymes with the progression of the disease.26 
The present study with adolescents from a Brazilian public 
school shows that HS had greater association with obesity 
and in its initial stage had mild transaminases alterations, 
which could lead to more severe hepatic alterations in the 
future.12,30
According to the Third Report of the National Cholesterol 
Education Expert Panel on Detection, Evaluation and 
Treatment of High Blood Cholesterol in Adults, one that can 
be applied to the general population, the metabolic syndrome 
is present in 60% of females and in 30% of males affected 
by HS. The presence of the metabolic syndrome carries a 
threefold increase risk of NASH among NAFLD subjects. The 
metabolic syndrome is particularly associated with high risk 
of fibrosis or cirrhosis, without differences in the degree of 
HS and of necroinflammatory activity enzymes.8
The present study showed a strong association between 
obesity and HS among Brazilian adolescents from a public 
high school. Therefore, adolescents of low-income families, 
who are overweight, obese and asymptomatic constitute a 
risk group for the development of hepatic repercussions, 
in addition to metabolic alterations. This suggests that 
adolescents from low-income urban populations should be 
targeted for prevention policies and programs to identify 
risks of HS and their health consequences.
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